Mechanism of TRIM24 to Regulate Resistance of Gefitinib in NSCLC cells

Background and objective Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) resistance significantly limits its use in clinical practice. Study found that TRIM24 was overexpressed in non-small cell lung cancer (NSCLC) tissues and regulate cell growth, cell cycle and apoptosis in l...

Full description

Bibliographic Details
Main Authors: Haiying LI, Qingling WANG, Haijun BAO, Heng ZHANG, Ying ZHUANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2016-01-01
Series:Chinese Journal of Lung Cancer
Subjects:
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2016.01.03
_version_ 1828815167428755456
author Haiying LI
Qingling WANG
Haijun BAO
Heng ZHANG
Ying ZHUANG
author_facet Haiying LI
Qingling WANG
Haijun BAO
Heng ZHANG
Ying ZHUANG
author_sort Haiying LI
collection DOAJ
description Background and objective Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) resistance significantly limits its use in clinical practice. Study found that TRIM24 was overexpressed in non-small cell lung cancer (NSCLC) tissues and regulate cell growth, cell cycle and apoptosis in lung cell lines. The aim of this study is to explore the mechanism of TRIM24 to regulate resistance of Gefitinib in NSCLC cells. Methods MTT and apoptosis were used to detect the change of cell grow and cell apoptosis with down-expression TRIM24 and ShTRIM24 with presence of Gefitinib. Meanwhile, Western blot was used to detect the expression of protein related to apoptosis and AKT signal path. Results TRIM24 interference could improve the effect of gefitinib on cell growth inhibition and upregulate the cell apoptosis in A549 cell. Down-regulated of endogenous TRIM24 and ShTRIM24 with Gifitinib could also reduce the protein related apoptosis, such as p-BAD and Bcl-2, and the protein PIK3CA related AKT signal path in A549 cell. Conclusion TRIM24 could regulate required resistance to Gefitinib via Akt pathway in NSCLC.
first_indexed 2024-12-12T10:38:20Z
format Article
id doaj.art-75af5e83705845f98e1b4963dbe8271d
institution Directory Open Access Journal
issn 1009-3419
1999-6187
language zho
last_indexed 2024-12-12T10:38:20Z
publishDate 2016-01-01
publisher Chinese Anti-Cancer Association; Chinese Antituberculosis Association
record_format Article
series Chinese Journal of Lung Cancer
spelling doaj.art-75af5e83705845f98e1b4963dbe8271d2022-12-22T00:27:07ZzhoChinese Anti-Cancer Association; Chinese Antituberculosis AssociationChinese Journal of Lung Cancer1009-34191999-61872016-01-01191242910.3779/j.issn.1009-3419.2016.01.03Mechanism of TRIM24 to Regulate Resistance of Gefitinib in NSCLC cellsHaiying LI0Qingling WANG1Haijun BAO2Heng ZHANG3Ying ZHUANG4Department of Pathology, College of Basic Medical Science, Xuzhou Medical College, Xuzhou 221000, ChinaDepartment of Pathology, College of Basic Medical Science, Xuzhou Medical College, Xuzhou 221000, ChinaDepartment of Pathology, College of Basic Medical Science, Xuzhou Medical College, Xuzhou 221000, ChinaDepartment of Pathology, College of Basic Medical Science, Xuzhou Medical College, Xuzhou 221000, ChinaDepartment of Pathology, College of Basic Medical Science, Xuzhou Medical College, Xuzhou 221000, ChinaBackground and objective Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) resistance significantly limits its use in clinical practice. Study found that TRIM24 was overexpressed in non-small cell lung cancer (NSCLC) tissues and regulate cell growth, cell cycle and apoptosis in lung cell lines. The aim of this study is to explore the mechanism of TRIM24 to regulate resistance of Gefitinib in NSCLC cells. Methods MTT and apoptosis were used to detect the change of cell grow and cell apoptosis with down-expression TRIM24 and ShTRIM24 with presence of Gefitinib. Meanwhile, Western blot was used to detect the expression of protein related to apoptosis and AKT signal path. Results TRIM24 interference could improve the effect of gefitinib on cell growth inhibition and upregulate the cell apoptosis in A549 cell. Down-regulated of endogenous TRIM24 and ShTRIM24 with Gifitinib could also reduce the protein related apoptosis, such as p-BAD and Bcl-2, and the protein PIK3CA related AKT signal path in A549 cell. Conclusion TRIM24 could regulate required resistance to Gefitinib via Akt pathway in NSCLC.http://dx.doi.org/10.3779/j.issn.1009-3419.2016.01.03Lung neoplasmsGefitinibEpidermal growth factor receptor tyrosine kinase inhibitor
spellingShingle Haiying LI
Qingling WANG
Haijun BAO
Heng ZHANG
Ying ZHUANG
Mechanism of TRIM24 to Regulate Resistance of Gefitinib in NSCLC cells
Chinese Journal of Lung Cancer
Lung neoplasms
Gefitinib
Epidermal growth factor receptor tyrosine kinase inhibitor
title Mechanism of TRIM24 to Regulate Resistance of Gefitinib in NSCLC cells
title_full Mechanism of TRIM24 to Regulate Resistance of Gefitinib in NSCLC cells
title_fullStr Mechanism of TRIM24 to Regulate Resistance of Gefitinib in NSCLC cells
title_full_unstemmed Mechanism of TRIM24 to Regulate Resistance of Gefitinib in NSCLC cells
title_short Mechanism of TRIM24 to Regulate Resistance of Gefitinib in NSCLC cells
title_sort mechanism of trim24 to regulate resistance of gefitinib in nsclc cells
topic Lung neoplasms
Gefitinib
Epidermal growth factor receptor tyrosine kinase inhibitor
url http://dx.doi.org/10.3779/j.issn.1009-3419.2016.01.03
work_keys_str_mv AT haiyingli mechanismoftrim24toregulateresistanceofgefitinibinnsclccells
AT qinglingwang mechanismoftrim24toregulateresistanceofgefitinibinnsclccells
AT haijunbao mechanismoftrim24toregulateresistanceofgefitinibinnsclccells
AT hengzhang mechanismoftrim24toregulateresistanceofgefitinibinnsclccells
AT yingzhuang mechanismoftrim24toregulateresistanceofgefitinibinnsclccells